Eva Isaksson

Eva Isaksson

Affiliated to Research
Telephone: +46852482621
Visiting address: Entrévägen 2, 18257 Danderyd
Postal address: D1 Kliniska vetenskaper, Danderyds sjukhus, D1 Neurologi Cerebrovaskulära sjukdomar, 171 77 Stockholm

About me

  • I am a medical doctor (MD), PhD, and certified research nurse with approximately 30 years of experience in clinical research and clinical trials within healthcare. Over the past 15 years, I have primarily worked with the planning, coordination, and management of academic multicentre studies in stroke in Sweden. I also have experience as a clinical trial monitor. I obtained my PhD from Karolinska Institutet in 2021.

    My research is primarily focused on the conduct of randomised controlled clinical trials, with particular emphasis on patient recruitment, recruitment processes, and factors influencing the ability of patients and study staff to participate in and conduct clinical studies. Another area of research concerns information provision and decision-making prior to participation in clinical trials.

    PhD Thesis

    I defended my PhD thesis in March 2021, entitled Recruitment to multicentre randomised controlled trials in stroke. Lessons learnt from the EFFECTS trial. The thesis was based on the EFFECTS trial, an academically initiated randomised controlled multicentre trial in stroke, in which I worked as Trial Manager.

    A central starting point for my thesis was the observation that many randomised controlled trials face difficulties in reaching their planned recruitment targets within the specified timeframe. Inadequate recruitment may result in prolonged recruitment periods, increased costs, and reduced statistical power, and may also have ethical implications. My research has therefore focused on identifying barriers to patient recruitment and on developing and evaluating strategies to improve recruitment in multicentre trials.

    Research Projects

    As part of my research, I have conducted several sub-studies using different methodological approaches.

    1. Study of study staff perceptions of recruitment barriers

    2. Intervention to improve patient recruitment

    3. Validation of the modified Rankin Scale

    Future Research

    My ongoing research has evolved from a primary focus on patient recruitment in clinical trials towards a broader perspective on how clinical studies are planned, conducted, and communicated to patients and study staff.

    My clinical experience as a research nurse, monitor, and Trial Manager in academic multicentre studies provides an important foundation for my research. The combination of practical experience in the conduct of clinical studies and my own research enables me to identify clinically relevant research questions and investigate them using scientific methods.

    I currently work as a Research Coordinator within the Department of Neurology at Danderyd Hospital and also have overall responsibility for the support function at the Clinical Research Centre (KFC). Through these roles, I remain closely involved in clinical research and the practical implementation of clinical studies. My work includes developing structures and processes that support researchers and clinical teams throughout the study lifecycle, from planning and initiation to study conduct and completion.

    Academic Qualifications

    PhD, 2021
    Karolinska Institutet

    Thesis: Recruitment to multicentre randomised controlled trials in stroke. Lessons learnt from the EFFECTS trial.

    Diploma in Clinical Trials / Certified Research Nurse, 2009
    Utbildningsrådet

Articles

All other publications

Grants

  • Swedish Research Council
    1 January 2024 - 31 December 2027
    The purpose of the trial is to study the prognostic impact of ECG investigation after stroke or Transient Ischemic Attack (TIA).The aim is to investigate if extended ECG screening after stroke or TIA as compared to standard ECG screening for atrial fibrillation reduces the occurrence of the primary composite endpoint of stroke, death and intracranial bleeding.P: Patients aged ≥70 years and admitted for ischemic stroke/TIA in Swedish stroke units. I: Extended long-term ECG-recording of 14 + 14 days duration using patch ECG, read in a core facility. Oral anticoagulation treatment will be suggested to all cases detected with atrial fibrillation in intervention and control arm unless contraindicated.C: Standard ECG recording of 48 hO: Primary outcome is a composite of stroke, all-cause mortality and intracerebral bleeding. Secondary and exploratory oucomes include the individual components of the primary endpoint, intracranial bleedning, myocardial infarction, major bleeding and pacemaker implantation. Endpoint and majority of baseline data will be collected from Swedish health care registers, mainly Riksstroke but also inpatient, drug prescription and cause of death register. Sample size is estimated at 2700. Pilot study commenced ni 2022, main trial is planned to recruit 2023-2026 and follow-up 2027-2028.Given a positive result, the study will give evidence to an investigation and treatment that will improve prognosis in a large group of patients with very poor prognosis.

Employments

  • Affiliated to Research, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2024-2027

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2021

News from KI

Events from KI